# Functional analysis of a novel variant in the COL5A1 gene in a Polish patient with the classical type of Ehlers–Danlos syndrome

**Authors:** Anna Junkiert-Czarnecka, Karolina Maciak, Magdalena M. Kacprzak, Agnieszka Łobodzińska, Agnieszka Sobczyńska-Tomaszewska, Aneta Jurkiewicz, Monika Gora, Beata Burzynska, Maria Pilarska-Deltow, Olga Haus

PMC · DOI: 10.3389/fgene.2025.1689587 · 2025-11-06

## TL;DR

A new genetic variant in the COL5A1 gene was found in a Polish girl with classical Ehlers–Danlos syndrome, leading to a truncated protein and confirming the diagnosis.

## Contribution

A novel COL5A1 variant was identified and functionally analyzed, providing insights into its role in classical EDS.

## Key findings

- A novel COL5A1 variant (c.2089-7_2089dupGTACACAG) was identified in a patient with classical EDS.
- The variant causes a premature stop codon and a truncated protein missing ~1,000 amino acids.
- The variant is de novo and disrupts the triple helical domain of type V collagen.

## Abstract

Ehlers–Danlos syndrome (EDS) is a clinically and genetically diverse group of inherited connective tissue disorders. According to the 2017 International Classification, 13 EDS subtypes are associated with pathogenic variants in 19 genes, most of which are involved in collagen synthesis or structure. The most common forms include classical (cEDS) and hypermobile (hEDS) types. Classical EDS is primarily caused by pathogenic variants in the COL5A1 and COL5A2 genes, which encode type V collagen, and less frequently by the c.934C>T variant in COL1A1. This study investigated the molecular basis of cEDS in a 9-year-old girl presenting clinical features consistent with this subtype. Whole-exome sequencing (WES) identified a novel variant in COL5A1: c.2089-7_2089dupGTACACAG. Functional analysis showed that this duplication causes a shift in the exon start site, resulting in a premature stop codon and a predicted truncated protein lacking approximately 1,000 amino acids. Family studies confirmed that the variant occurred de novo. This pathogenic variant, located in the triple helical domain of type V collagen, likely disrupts the final structure and function of the protein. The two-step diagnostic strategy combining molecular and functional testing enabled a rapid and definitive diagnosis for the patient.

## Linked entities

- **Genes:** COL5A1 (collagen type V alpha 1 chain) [NCBI Gene 1289], COL5A2 (collagen type V alpha 2 chain) [NCBI Gene 1290], COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277]
- **Diseases:** Ehlers–Danlos syndrome (MONDO:0020066)

## Full-text entities

- **Genes:** COL5A1 (collagen type V alpha 1 chain) [NCBI Gene 1289] {aka EDSC, EDSCL1, FMDMF}, COL5A2 (collagen type V alpha 2 chain) [NCBI Gene 1290] {aka EDSC, EDSCL2}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}
- **Diseases:** inherited connective tissue disorders (MESH:C535910), EDS (MESH:D004535), Classical EDS (MESH:C536194)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** c.2089-7_2089dupGTACACAG, c.934C>T

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12630569/full.md

---
Source: https://tomesphere.com/paper/PMC12630569